3.0
21 Jan 2026
Current employee
Recommend
CEO approval
Business outlook
Pros
Competitive OTE and provides a satisfying challenge.
Cons
Biotech market is bad right now and only 1 or 2 salespersons are hitting quota so nobody is making close to their OTE. Constant turnover in leadership and lack of consistent direction